DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo


company name or ticker

The Market's 10 Best Stocks

Look back a decade, and you'll find that nearly all the top-performing stocks have one thing in common.

Alexion's Rare Disease Model Analyzed

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results -

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog

Insider Trading Alert - DXCM, ALXN And FRGI Traded By Insiders

3 Companies Growing Faster Than MannKind Corporation

MannKind may be on the precipice of growth surge thanks to Afrezza, but these three biotech stocks are still growing faster than MannKind.

Alexion Announces New Share Repurchase Program of $500M - Analyst Blog

Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog

The New #47 Most Shorted Nasdaq 100 Component: Alexion Pharmaceuticals

ChemoCentryx: Can It Break Into The Soliris Market?

Are Investors Signaling Optimism in Biotechs Through Short Interest?

See More Articles...